Cancer therapeutics trang 1 tải miễn phí từ TAILIEUCHUNG

"Cancer therapeutics" trang 1 - tải miễn phí từ Tailieuchung

HORMONE THERAPY IN BREAST AND PROSTATE CANCER

HORMONE THERAPY IN BREAST AND PROSTATE CANCER

423 50 0

Nanoparticle based targeted therapeutics in head-and-neck cancer

Nanoparticle based targeted therapeutics in head-and-neck cancer

14 59 0

Autophagy modulating therapeutics inhibit ovarian cancer colony generation by polyploid giant cancer cells (PGCCs)

Autophagy modulating therapeutics inhibit ovarian cancer colony generation by polyploid giant cancer cells (PGCCs)

13 14 1

Differential modulation of nicotine-induced gemcitabine resistance by GABA receptor agonists in pancreatic cancer cell xenografts and in vitro

Differential modulation of nicotine-induced gemcitabine resistance by GABA receptor agonists in pancreatic cancer cell xenografts and in vitro

12 24 1

DISEASES AND DISORDERS A Nursing Therapeutics Manual - THIRD EDITION

DISEASES AND DISORDERS A Nursing Therapeutics Manual - THIRD EDITION

1 77 0

FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study

FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study

8 38 1

High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer

High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer

9 25 1

A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping

A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping

11 38 1

Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy

Comprehensive genomic profiling in routine clinical practice leads to a low rate of benefit from genotype-directed therapy

8 64 1

In vitro and in vivo activity of melflufen (J1) in lymphoma

In vitro and in vivo activity of melflufen (J1) in lymphoma

9 35 1

Preclinical evaluation of Sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastases

Preclinical evaluation of Sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastases

9 33 1

Transposon activation mutagenesis as a screening tool for identifying resistance to cancer therapeutics

Transposon activation mutagenesis as a screening tool for identifying resistance to cancer therapeutics

15 31 1

Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer

Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer

12 72 0

Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem celllike phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo

Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem celllike phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo

13 37 0

BREAST CANCER – RECENT ADVANCES IN BIOLOGY, IMAGING AND THERAPEUTICS

BREAST CANCER – RECENT ADVANCES IN BIOLOGY, IMAGING AND THERAPEUTICS

438 51 0

A pharmacopoeia including the outlines of materia medica and therapeutics for the use of practitioners and students of veterinary medicine

A pharmacopoeia including the outlines of materia medica and therapeutics for the use of practitioners and students of veterinary medicine

325 41 0

MANAGEMENT OF GASTRIC CANCER

MANAGEMENT OF GASTRIC CANCER

158 45 0

báo cáo hóa học:

báo cáo hóa học:" Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics"

9 47 0

báo cáo hóa học:

báo cáo hóa học:" Scope of nanotechnology in ovarian cancer therapeutics"

10 33 0

Báo cáo khoa học: Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics

Báo cáo khoa học: Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics

13 39 0

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.